Clarity Pharmaceuticals (1F4.F) Q3 2026 Earnings

27AugConfirmed
Q3 2025
Q1 2026
Q3 2026
-0.09
-0.07
-0.06
-0.04

Details

Expected EPS
-0.09001830298700911
Actual EPS
-0.0741874713691034
Surprise EPS
0.02
Surprise Percent
+17.59%

Description

Clarity Pharmaceuticals (1F4.F) has reported earnings of -0.0741874713691034 per share for Q3 2026.

0 Comments

Share your thoughts